Nikon establishes “Nikon BioImaging Lab” in Boston to support drug discovery research

Development of customized drug discovery assays and image analyses upon request June 13, 2019 Nikon Corporation (Toshikazu Umatate, President, Tokyo) and its subsidiary Nikon Instruments Inc. (Toshiaki Nagano, President, NY, USA) have established the Nikon BioImaging Lab in Boston, USA to provide contract imaging and assay services for pharmaceutical companies and venture companies involved in... Read more

Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform

Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance •Scientific modeling, simulation and digital assets of worldwide trials knowledge and know-how combine to accelerate developments in personalized health, for the benefit of the patient •Life Sciences industry will also benefit from the platform effect spanning... Read more

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC) PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., June 11, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration... Read more

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

Basel, 04 June 2019 Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine Venclexta/Venclyxto plus Gazyva/Gazyvaro showed improvements across multiple efficacy measures compared to Gazyva/Gazyvaro plus chlorambucil, including progression-free survival and deep remissions as determined by... Read more

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies

Agilent Survey of Pharma Lab Leaders Uncovers Challenges in Workflow and Laboratory Efficiencies SANTA CLARA, Calif., June 4, 2019 Agilent Technologies Inc. (NYSE: A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650... Read more

GE Healthcare and Rockwell Automation Collaborate to Drive the Next Generation of Bioprocessing Automation

March 28, 2019 Collaboration will help drug manufacturers improve efficiencies, get to market faster and deliver personalized medicines with innovative solutions Joint work is pivotal step in transforming biopharmaceutical manufacturing to meet the needs of the biopharma 4.0 era Chicago, IL and Milwaukee, WI, US – March 28, 2019 – GE Healthcare and Rockwell Automation are combining their... Read more

MilliporeSigma Expands Cell Culture Media Production Facility in Irvine

Demonstrates MilliporeSigma’s commitment to the UK Only MilliporeSigma facility to produce both liquid and powder cell culture media Irvine, Scotland, May 27, 2019 — MilliporeSigma, a leading science and technology company, today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility. The site is MilliporeSigma’s only location where both liquid and... Read more

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Basel, 16 May 2019 Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia Fixed 12-month treatment with Venclexta plus Gazyva significantly reduced risk of disease progression or death by 67% compared to a current standard-of-care Approval for expanded use of Venclexta offers more adults with chronic lymphocytic leukaemia... Read more

A wholly-owned subsidiary, Takara Biotechnology (Dalian) Co., Ltd. Acquires ISO:13485 certification

2019/05/07 Kusatsu/Shiga, Japan – April 24, 2019 –  Takara Bio Inc. (Takara Bio) announced that Takara Biotechnology (Dalian) Co., Ltd. (Dalian city, China, hereafter “Takara Biotechnology (Dalian)”), a wholly-owned subsidiary of Takara Bio has acquired ISO 13485:2016 certification, an international standard for quality management system of medical devices and diagnostic pharmaceuticals.   Takara Biotechnology (Dalian) is a... Read more

BD Receives FDA Approval for Fully Sterile Chlorhexidine Gluconate Antiseptic Skin Preparation

FRANKLIN LAKES, N.J., April 30, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep™ skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the... Read more